(Q30480599)

14 September 2017

1 reference

Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes (English)

1 reference

14 September 2017

2 references

1 reference

Annemarie M M Vlaar

1

1 reference

14 September 2017

Marinus J P G van Kroonenburgh

series ordinal

2

1 reference

14 September 2017

Alfons G H Kessels

series ordinal

3

1 reference

14 September 2017

Wim E J Weber

series ordinal

4

1 reference

14 September 2017

1 September 2007

1 reference

14 September 2017

1 reference

14 September 2017

7

1 reference

14 September 2017

27

1 reference

Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

How useful is [123I]beta-CIT SPECT in clinical practice?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

New developments in diagnosis and treatment of Parkinson's disease--from basic science to clinical applications.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

PET and SPECT functional imaging studies in Parkinsonian syndromes: from the lesion to its consequences

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Neuroprotection and pharmacotherapy for motor symptoms in Parkinson's disease.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Functional brain imaging in the differential diagnosis of Parkinson's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Measuring inconsistency in meta-analyses

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Conducting systematic reviews of diagnostic studies: didactic guidelines

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

[123I]beta-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs Later L-DOPA.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

[123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Issues in the early diagnosis of Parkinson's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

A clinicopathologic study of 100 cases of Parkinson's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Accuracy of clinical diagnosis in parkinsonism--a prospective study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

SPECT imaging of dopamine D2 receptors with 123I-IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Risk tables for parkinsonism and Parkinson's disease.

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Idiopathic hyposmia as a preclinical sign of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Brain parenchyma sonography detects preclinical parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Diagnostic performance of a 3-D automated quantification method of dopamine D2 receptor SPECT studies in the differential diagnosis of parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

[123I]beta-CIT and SPECT in essential tremor and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Dopamine transporter SPECT using fast kinetic ligands: 123I-FP-beta-CIT versus 99mTc-TRODAT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

[123I]beta-CIT SPECT visualizes dopamine transporter loss in de novo parkinsonian patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

123I-IPT brain SPECT study in essential tremor and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

[123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Differential distribution of striatal [123I]beta-CIT in Parkinson's disease and progressive supranuclear palsy, evaluated with single-photon emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Comparison of striatal dopamine D2 receptors in Parkinson's disease and progressive supranuclear palsy patients using [123I] iodobenzofuran single-photon emission computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Measuring the rate of progression of Parkinson's disease over a 5-year period with beta-CIT SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3‐month observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Relative quantification of signal on T2-weighted images in the basal ganglia: limited value in differential diagnosis of patients with parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Quantitative analysis of striatal dopamine D2 receptors with 123 I-iodolisuride SPECT in degenerative extrapyramidal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Measuring the progression of idiopathic Parkinson's disease with [123I] beta-CIT SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-7-27

Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Early-stage [123I]beta-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson's disease

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

99mTc-TRODAT-1 imaging of multiple system atrophy

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

[Systematic reviews in practice. X. Searching, selecting and the methodological assessment of diagnostic evaluation research]

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Is altropane SPECT more sensitive to fluoroDOPA PET for detecting early Parkinson's disease?

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

The practice of systematic reviews. II. Searching and selection of studies

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

IBZM-SPECT as predictor for dopamimetic responsiveness of patients with de novo parkinsonian syndrome.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2064928

26 November 2018

1 reference

12 December 2020

123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism

1 reference

12 December 2020

1 reference

12 December 2020

Striatal dopamine D2 receptor alterations and response to L-DOPA in Parkinson's disease. A [123I]IBZM SPET study

1 reference

12 December 2020

123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism

1 reference

12 December 2020

Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography

1 reference

12 December 2020

[The differential diagnosis of Parkinson diseases--123I-IBZM-SPECT vs. the apomorphine test]

1 reference

12 December 2020

Correlation of clinical response in apomorphine test with D2-receptor status as demonstrated by 123I IBZM-SPECT

1 reference

12 December 2020

123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonism

1 reference

12 December 2020

123I-IBZM SPECT: reconstruction methodology and results in parkinsonism and dystonia

1 reference

12 December 2020

Comparison of 123I-IBZM SPECT and 11C-raclopride PET findings in patients with parkinsonism

1 reference

12 December 2020

Iodine-123-IBF SPECT evaluation of extrapyramidal diseases

1 reference

12 December 2020

Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosis

1 reference

12 December 2020

The evolution of diagnosis in early Parkinson disease. Parkinson Study Group

1 reference

12 December 2020

A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Parkinson Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2377-7-27

1 reference

Dimensions Publication ID

14 September 2017

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1471-2377-7-27

1 reference

14 September 2017

PubMed publication ID

17764571

1 reference